1. Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer
   Lukas Käsmann et al, 2017, Lung CrossRef
2. Effect of silencing TEM8 gene on proliferation, apoptosis, migration and invasion of XWLC‑05 lung cancer cells
   Quan Gong et al, 2017, Molecular Medicine Reports CrossRef
3. Preoperative neutrophil-to-lymphocyte ratio behaves as an independent prognostic factor even in patients with postoperative complications after curative resection for gastric cancer
   Jaume Tur-Martínez et al, 2022, Langenbeck's Archives of Surgery CrossRef
4. A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC
   Bing Han et al, 2023, BMC Pulmonary Medicine CrossRef
5. A meta-analysis of the impact of neutrophil-to-lymphocyte ratio on treatment outcomes after radiotherapy for solid tumors
   Noorie Choi et al, 2019, Medicine CrossRef
6. Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis
   Shu-Ling Zhang et al, 2020, Radiation Oncology CrossRef
7. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions
   Zhexuan Lin et al, 2016, European Journal of Pharmacology CrossRef
8. Dynamic evaluation of neutrophil-to-lymphocyte ratio as prognostic factor in stage III non-small cell lung cancer treated with chemoradiotherapy
   V. Palomar-Abril et al, 2020, Clinical and Translational Oncology CrossRef
9. Elevated peripheral absolute monocyte count related to clinicopathological features and poor prognosis in solid tumors: Systematic review, meta‐analysis, and meta‐regression
   Shu Wen et al, 2021, Cancer Medicine CrossRef
10. Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer
    Charnay Cunningham et al, 2023, Pharmaceuticals CrossRef
11. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies
    Zubing Mei et al, 2017, Cancer Treatment Reviews CrossRef